reported that romidepsin can induce tumour cells and T cells to secrete T cell chemokines and recruit T cells to accumulate, thus improving the efficacy of PD1 immunotherapy in a mouse lung adenocarcinoma model.29 Here, PDCD1 is linked to lung adenocarcinoma.